Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 6/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 5/20 | 0.43 |
| ▸ | CTSS | P25774 | 4/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | KLK7 | P49862 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.36 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29050983 | 0.99 | CACNA1B (0.53) | CACNA1BHDAC4HDAC1HDAC6CTSK | |
| SCHEMBL29050985 | 0.99 | CACNA1B (0.53) | CACNA1BHDAC4HDAC1HDAC6CTSK | |
| SCHEMBL30044916 | 0.93 | CACNA1B (0.55) | CACNA1BHDAC4HDAC1HDAC6CTSK | |
| SCHEMBL192185 | 0.90 | CACNA1B (0.48) | CACNA1BHDAC4HDAC1HDAC6CTSK | |
| SCHEMBL376117 | 0.90 | CACNA1B (0.48) | CACNA1BHDAC4HDAC1HDAC6CTSK | |
| SCHEMBL4233928 | 0.90 | CACNA1B (0.48) | CACNA1BHDAC4HDAC1HDAC6CTSK | |
| SCHEMBL29051012 | 0.89 | CACNA1B (0.45) | CACNA1BHDAC4HDAC1HDAC6CTSK | |
| SCHEMBL29488044 | 0.89 | CACNA1B (0.45) | CACNA1BHDAC4HDAC1HDAC6CTSK | |
| SCHEMBL29051004 | 0.89 | CACNA1B (0.45) | CACNA1BHDAC4HDAC1HDAC6CTSK | |
| SCHEMBL6842296 | 0.89 | CACNA1B (0.48) | CACNA1BHDAC4HDAC1HDAC6CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230382886-A1 | CONJUGATED TLR7 AND NOD2 AGONISTS | UNIVERZA V LJUBLJANI (SI) | 2023-11-30 | — | — | US | disclosed |
| US-20230382886-A1 | CONJUGATED TLR7 AND NOD2 AGONISTS | UNIVERZA V LJUBLJANI (SI) | 2023-11-30 | — | — | US | disclosed |
| EP-4232094-A1 | CONJUGATED TLR7 AND NOD2 AGONISTS | Univerza V Ljubljani (SI) | 2023-08-30 | — | — | EP | disclosed |
| WO-2022084417-A1 | CONJUGATED TLR7 AND NOD2 AGONISTS | UNIVERZA V LJUBLJANI (SI) | 2022-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382886-A1 | CONJUGATED TLR7 AND NOD2 AGONISTS | NOD2, TLR7, TLR9 | CACNA1B 4712/4885HDAC4 751/4885HDAC1 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.